Journal Article

DKFZ-2023-00390

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.

Tintelnot, J. ; Xu, Y. ; Lesker, T. R. ; Schönlein, M. ; Konczalla, L. ; Giannou, A. D. ; Pelczar, P. ; Kylies, D. ; Puelles, V. G. ; Bielecka, A. A. ; Peschka, M. ; Cortesi, F. ; Riecken, K. ; Jung, M. ; Amend, L. ; Bröring, T. S. ; Trajkovic-Arsic, M.DKFZ* ; Siveke, J.DKFZ* ; Renné, T. ; Zhang, D. ; Boeck, S. ; Strowig, T. ; Uzunoglu, F. G. ; Güngör, C. ; Stein, A. ; Izbicki, J. R. ; Bokemeyer, C. ; Sinn, M. ; Kimmelman, A. C. ; Huber, S. ; Gagliani, N.

2023
Nature Publ. Group London [u.a.]

This record in other databases:  

Please use a persistent id in citations: doi:10.1038/s41586-023-05728-y

Abstract: Pancreatic ductal adenocarcinoma (PDAC) is expected to be the second most deadly cancer by 2040, owing to the high incidence of metastatic disease and limited responses to treatment1,2. Less than half of all patients respond to the primary treatment for PDAC, chemotherapy3,4, and genetic alterations alone cannot explain this5. Diet is an environmental factor that can influence the response to therapies, but its role in PDAC is unclear. Here, using shotgun metagenomic sequencing and metabolomic screening, we show that the microbiota-derived tryptophan metabolite indole-3-acetic acid (3-IAA) is enriched in patients who respond to treatment. Faecal microbiota transplantation, short-term dietary manipulation of tryptophan and oral 3-IAA administration increase the efficacy of chemotherapy in humanized gnotobiotic mouse models of PDAC. Using a combination of loss- and gain-of-function experiments, we show that the efficacy of 3-IAA and chemotherapy is licensed by neutrophil-derived myeloperoxidase. Myeloperoxidase oxidizes 3-IAA, which in combination with chemotherapy induces a downregulation of the reactive oxygen species (ROS)-degrading enzymes glutathione peroxidase 3 and glutathione peroxidase 7. All of this results in the accumulation of ROS and the downregulation of autophagy in cancer cells, which compromises their metabolic fitness and, ultimately, their proliferation. In humans, we observed a significant correlation between the levels of 3-IAA and the efficacy of therapy in two independent PDAC cohorts. In summary, we identify a microbiota-derived metabolite that has clinical implications in the treatment of PDAC, and provide a motivation for considering nutritional interventions during the treatment of patients with cancer.

Note: 2023 Mar;615(7950):168-174

---

Contributing Institute(s):

1. DKTK ED ES zentral (ED01)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2023

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Chemical Reactions ; Clarivate Analytics Master Journal List ; Current Contents - Agriculture, Biology and Environmental Sciences ; Current Contents - Life Sciences ; Current Contents - Physical, Chemical and Earth Sciences ; DEAL Nature ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 60 ; Index Chemicus ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record

---